BusinessPress ReleaseWuXi Vaccines Passes First GMP Audit by a Global Vaccine Leader SUZHOU, China, Dec. 6, 2023 /PRNewswire/ — WuXi Vaccines, a leading global… CISION PRNewswireDecember 6, 2023
BusinessPress ReleaseTechVERTICAL INSTITUTE REVOLUTIONISES CAREER DEVELOPMENT WITH CUTTING-EDGE COURSES AND EXPERT-LED INSTRUCTION Vertical Institute (VI) is a leading provider of cutting-edge courses, addressing the… CISION PRNewswireDecember 6, 2023
Press ReleaseAntengene Announces XPOVIO® Regulatory Approval in Macau for the Treatment of Relapsed and/or Refractory Multiple Myeloma XPOVIO® (selinexor) is the first and only exportin 1 (XPO1) inhibitor approved… CISION PRNewswireDecember 6, 2023
Press ReleaseQilu Pharmaceutical Announces Results from Phase II Study for iparomlimab for Advanced Solid Tumors at ESMO Asia, with an ORR of 45.8% JINAN, China, Dec. 6, 2023 /PRNewswire/ — Qilu Pharmaceutical presented the latest… CISION PRNewswireDecember 6, 2023
Press ReleaseKoselugo now available in Malaysia for paediatric patients with symptomatic neurofibromatosis type 1 (NF1) plexiform neurofibromas KUALA LUMPUR, Malaysia, Dec. 6, 2023 /PRNewswire/ — AstraZeneca’s Koselugo (selumetinib) is… CISION PRNewswireDecember 6, 2023
Press ReleaseTechOKX Ventures Joins Ethereum Climate Platform As a Launch Partner to Advance Sustainability in Web3 SINGAPORE, Dec. 6, 2023 /PRNewswire/ — OKX Ventures, the investment arm of… CISION PRNewswireDecember 6, 2023
BusinessPress ReleaseTechUxin Limited Announces Successful Validation of Superstore Business Model, Significant Reduction in Losses, and Target of Achieving Overall Profitability by 2024 BEIJING, Dec. 6, 2023 /PRNewswire/ — Uxin Limited ("Uxin" or the "Company")… CISION PRNewswireDecember 6, 2023
BusinessPress ReleaseTechQianhai's Intensive Digital Industrial Layout to Facilitate the Development of the GBA SHENZHEN, China, Dec. 6, 2023 /PRNewswire/ — Digital trade is one of… CISION PRNewswireDecember 6, 2023
